Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Interest Income Over TimeStrong
Percentile Rank92
3Y CAGR+13.8%
5Y CAGR+25.8%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+13.8%/yr
vs +31.7%/yr prior
5Y CAGR
+25.8%/yr
Recent deceleration
Acceleration
-17.9pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$13.14M+2.9%
2024$12.77M-39.0%
2023$20.93M+134.8%
2022$8.91M+2032.5%
2021$418000.00-90.0%
2020$4.16M-18.5%
2019$5.11M+72.5%
2018$2.96M-
2017$0.00-
2016$0.00-